PHLI Stock Overview
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
PacificHealth Laboratories, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -99.00% |
3 Year Change | -100.00% |
5 Year Change | -99.98% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
PHLI | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | 4.1% | 1.2% |
1Y | -99.0% | -26.0% | 24.9% |
Return vs Industry: PHLI underperformed the US Personal Products industry which returned -25.4% over the past year.
Return vs Market: PHLI underperformed the US Market which returned 24.7% over the past year.
Price Volatility
PHLI volatility | |
---|---|
PHLI Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 8.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PHLI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHLI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | n/a | n/a | www.pacifichealthlabs.com |
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel.
PacificHealth Laboratories, Inc. Fundamentals Summary
PHLI fundamental statistics | |
---|---|
Market cap | US$20.00 |
Earnings (TTM) | -US$943.60k |
Revenue (TTM) | US$6.67m |
0.0x
P/S Ratio0.0x
P/E RatioIs PHLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHLI income statement (TTM) | |
---|---|
Revenue | US$6.67m |
Cost of Revenue | US$4.10m |
Gross Profit | US$2.57m |
Other Expenses | US$3.51m |
Earnings | -US$943.60k |
Last Reported Earnings
Sep 30, 2012
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did PHLI perform over the long term?
See historical performance and comparison